undamentalytics Newsletter
Sign in

Privia Health Group, Inc. key statistics and ratios

In fiscal 2025, Privia Health Group, Inc. had return on equity of 3.3% and a net margin of 1.1%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Net margin1.0%3.8%−19.5%−0.6%1.4%0.8%1.1%1.2%
Return on equity7.7%24.6%−65.6%−1.9%4.4%2.4%3.3%3.7%
Return on assets—9.5%−37.1%−1.2%2.6%1.3%1.8%2.0%
Effective tax rate13.2%−31.7%——27.5%38.8%32.3%39.7%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

2 of 2 checks passed · June 30, 2026
What it owns · $1.5bn
Short-term assets $1.0bnLonger-term assets $463m
What it owes, and who funded it · $1.4bn
Short-term liabilities $634mLonger-term liabilities $16mShareholders' equity $782m
  • Short-term assets cover short-term liabilities $1.0bn of assets due within a year against $634m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $1.0bn short-term assets against $16m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Privia Health Group, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

21 /100

Weak moat

How hard Privia Health Group's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median 1.3% of total assets over 6 years.

  • Durability 0 / 20

    Operating margin has been a median 0.8%; its worst year was -20.1%.

  • Cash conversion 12 / 20

    Free cash flow was positive in 6 of 6 years, at a median 4.6% of revenue.

  • Discipline 8 / 20

    The diluted share count rose 33.6% over five years; stock-based pay has been a median 3.4% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (26 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: PRVA vs RDNTHIMS vs PRVAAVAH vs PRVAEVH vs PRVA

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Privia Health Group, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Privia Health Group, Inc.